TrialHepatology international2016

Ritonavir-boosted danoprevir-based regimens in treatment-naive and prior null responders with HCV genotype 1 or 4 and compensated cirrhosis.

Edward J Gane et al.PubMed ↗Publisher ↗

No numbers read from the abstract.